Chemotherapy is a standard treatment for the most common form of leukemia — chronic lymphocytic leukemia (CLL). A combination of pills may offer CLL patients new, better and gentler options.

Most patients with a slow-growing form of non-Hodgkin lymphoma respond well to therapy at first. But the disease can return and become resistant to therapy. A new medication may change this pattern.

Treatment for follicular lymphoma — the most common type of non-Hodgkin lymphoma — often comes with serious side effects. New research may change that for many patients.